Cystinuria is a rare genetic kidney stone disorder, but for the people who live with it, it can be a lifelong and frustrating condition. Unlike many kidney stones that form from calcium oxalate or uric acid, cystine stones develop because of an inherited problem in the kidney’s ability to reabsorb cystine, an amino acid. When too much cystine remains in the urine, it can crystallize and form recurrent stones. An integrative approach to cystinuria does not replace standard medical care. Instead, it builds on it by focusing on the daily factors that influence cystine stone formation, especially hydration, urine pH, diet quality, sodium intake, protein intake, and long-term kidney protection.
A recent 2025 study published in Clinical Kidney Journal adds important nuance to dietary advice. In patients with cystinuria, higher protein intake was moderately associated with higher urinary cystine excretion, while salt intake had only a small and statistically non-significant association. This does not mean salt is irrelevant, but it suggests that fluid intake and urine alkalinization remain the most important targets, with protein moderation playing a supportive role.
By Majd Isreb, MD, FACP, FASN, IFMCP
What Is Cystinuria?
Cystinuria is an inherited disorder that causes excessive urinary loss of cystine and other dibasic amino acids, including lysine, arginine, and ornithine. The clinical problem is mainly cystine because it is poorly soluble in urine, especially when the urine is acidic or concentrated.
When urinary cystine concentration exceeds its solubility, cystine crystals can form. These crystals may grow into stones in the kidneys, ureters, or bladder. Cystine stones can be hard, recurrent, and difficult to manage. Many patients require repeated imaging, medications, dietary changes, and sometimes surgical procedures.
Cystinuria often presents in childhood, adolescence, or early adulthood, but diagnosis may be delayed if recurrent stones are treated without identifying their composition.
The Genetics of Cystinuria
Cystinuria is usually inherited in an autosomal recessive pattern. This means a person typically inherits disease-causing variants from both parents.
The main genes involved are:
SLC3A1
This gene encodes rBAT, a component of the transporter system responsible for reabsorbing cystine and dibasic amino acids in the proximal tubule of the kidney.
SLC7A9
This gene encodes b0,+AT, the transporter partner that works with rBAT. Variants in this gene can also impair cystine transport.
When these transporters do not work properly, cystine is not adequately reabsorbed from the filtered urine. The result is high urinary cystine excretion and increased risk of cystine stone formation.
Older classification systems divided cystinuria into type A, type B, and type AB depending on whether the variants involved SLC3A1, SLC7A9, or both. Genetic testing can help confirm the diagnosis, guide family counseling, and identify affected siblings or relatives who may benefit from early prevention.
The Natural History of Cystinuria
Cystinuria is a lifelong condition. The main clinical pattern is recurrent kidney stone formation. Some patients may go years between stones, while others may experience frequent episodes.
Common complications include:
Recurrent flank pain, blood in the urine, urinary obstruction, urinary tract infections, repeated emergency visits, repeated urologic procedures, anxiety around stone recurrence, and reduced quality of life.
Over time, recurrent obstruction, infection, inflammation, and surgical interventions may contribute to kidney scarring or chronic kidney disease. Kidney failure is uncommon, but the risk is higher in patients with severe recurrent disease, delayed diagnosis, repeated bilateral obstruction, or complicated infections.
The goal of treatment is not only to remove stones when they occur, but to prevent new stones from forming.
Current Medical Management of Cystinuria
Current treatment focuses on reducing cystine concentration in the urine and increasing cystine solubility.
High Fluid Intake
This is the foundation of cystinuria management. The goal is to dilute urinary cystine enough that it does not crystallize. Many guidelines recommend aiming for urine output of at least 3 liters per day in adults, though individualized targets may vary.
Because cystine can crystallize overnight when urine becomes more concentrated, fluid intake often needs to be distributed across the day and sometimes includes evening or nighttime hydration.
Urine Alkalinization
Cystine is more soluble in alkaline urine. Potassium citrate or potassium bicarbonate is often used to raise urine pH. A common target is around pH 7.0 to 7.5.
This requires monitoring. If urine pH becomes too high, especially above 7.5, the risk of calcium phosphate stones may increase. This is why patients should not simply “alkalinize more” without medical supervision.
Sodium and Protein Reduction
Traditional recommendations often include lowering sodium and moderating animal protein intake. Sodium restriction may reduce cystine excretion in some studies and is still commonly recommended, especially because it benefits blood pressure and kidney health.
Protein moderation is also important, especially animal protein, which is higher in methionine, a precursor of cystine. The goal is not extreme protein restriction, which can be harmful, but a balanced intake that avoids excess.
Cystine-Binding Thiol Drugs
When hydration, alkalinization, and diet are not enough, medications such as tiopronin or D-penicillamine may be used. These drugs bind cystine and form more soluble compounds, reducing stone risk.
Captopril has also been discussed historically because it contains a thiol group, but it is generally less effective and is not usually the main cystine-binding therapy.
Join us to end the kidney disease epidemic
Side Effects of Current Medical Therapy
Cystine-binding medications can be helpful, but they may cause side effects and require careful monitoring.
Tiopronin is often better tolerated than D-penicillamine, but side effects may include gastrointestinal discomfort, rash, fatigue, oral ulcers, joint symptoms, blood count abnormalities, proteinuria, nephrotic syndrome, and, rarely, membranous nephropathy.
D-penicillamine can cause similar side effects and may be associated with more frequent intolerance. Potential adverse effects include rash, nausea, taste changes, mouth ulcers, leukopenia, thrombocytopenia, proteinuria, autoimmune reactions, and kidney injury.
Because of these risks, the integrative goal is to optimize foundational measures, especially hydration, urine pH, and nutrition, so that medication exposure can be minimized when clinically appropriate. However, patients with severe cystinuria should not stop prescribed medications without working with their nephrologist or urologist.
Integrative Approach to Cystinuria: Start With Hydration
Hydration is the most important nutritional therapy for cystinuria. The purpose is simple: dilute cystine.
Practical hydration strategies include drinking water consistently throughout the day, using a large measured bottle, spreading intake rather than drinking most water at once, adding fluids in the evening when appropriate, and adjusting intake during exercise, heat exposure, travel, fasting, or illness.
Patients can also monitor urine color as a rough guide, but 24-hour urine testing is much more accurate. The key target is urine volume, not just fluid intake. A patient may drink a lot but still produce insufficient urine if they sweat heavily, exercise, use saunas, or live in a hot climate.
Integrative Approach to Cystinuria: Urine pH and Alkaline Nutrition
Urine alkalinization is central to cystinuria care because cystine becomes more soluble as urine pH rises.
Medication-based alkalinization with potassium citrate is often needed. However, diet can support a less acidic urine environment. A diet rich in vegetables and fruits generally provides a higher alkali load than a diet dominated by animal protein, processed grains, and salt-heavy packaged foods.
This does not mean that diet alone can replace potassium citrate. In many patients, it cannot. But a plant-forward dietary pattern may reduce acid load, support citrate status, and improve overall cardiometabolic and kidney health.
Good options include vegetables, fruits that fit the patient’s potassium needs, legumes in appropriate portions, whole grains, nuts and seeds in moderation, and herbs or spices instead of salty seasoning blends.
Patients with advanced CKD or hyperkalemia risk need individualized guidance because some potassium-rich foods and potassium-based alkali therapies may not be appropriate.
Integrative Approach to Cystinuria: Protein Moderation, Not Protein Fear
The 2025 Clinical Kidney Journal study provides an important update. In 41 adults with recurrent cystine stones followed with repeated 24-hour urine collections, an increase in urinary urea reflecting about 10 grams per day higher protein intake was associated with higher urinary cystine excretion. In contrast, higher urinary sodium, reflecting salt intake, showed only a small and non-significant association.
The practical message is not that patients should avoid protein. Protein is essential for muscle, immune function, wound healing, and metabolic health. The message is that excess protein, especially excess animal protein, may increase cystine burden.
A reasonable integrative strategy is to avoid high-protein diets, especially bodybuilding-style or ketogenic patterns that emphasize large amounts of meat, poultry, fish, and eggs. Protein intake should be individualized based on body size, kidney function, age, activity level, and nutritional status.
For many adults with cystinuria, a moderate protein intake, often around 0.8 to 1.0 g/kg/day depending on clinical context, may be reasonable. Plant-forward protein sources may help reduce dietary acid load and methionine exposure, but portions still matter.
Integrative Approach to Cystinuria: Salt Still Matters
The recent study found that salt intake had less impact on urinary cystine excretion than protein intake. However, this should not be interpreted as permission to ignore sodium.
Lower sodium intake still supports kidney health, blood pressure control, and stone prevention more broadly. It may also help reduce urinary calcium in patients who form mixed stones or have other stone risk factors.
The practical approach is to reduce ultra-processed foods, fast food, salty snacks, processed meats, canned soups, restaurant sauces, and high-sodium condiments. Patients should learn to read labels and aim for a sodium intake that fits their clinician’s recommendations.
For many adults, a practical target is less than 2,300 mg of sodium per day, and in some cases closer to 1,500 to 2,000 mg per day if blood pressure, kidney disease, or stone risk supports that goal.
A Food Pattern for Integrative Approach to Cystinuria
A cystinuria-supportive diet is best understood as a balanced, plant-forward kidney stone prevention pattern.
The plate may include:
Vegetables as the foundation, fruit as tolerated, moderate portions of whole grains, moderate protein with less emphasis on animal protein, limited processed foods, low-sodium seasonings, and enough calories to avoid unintentional weight loss.
This pattern supports several goals at once: lower acid load, lower sodium exposure, avoidance of excessive protein, improved blood pressure, better gut microbiome diversity, and better long-term kidney protection.
What to Monitor in the Integrative Approach to Cystinuria
Cystinuria should be managed with objective monitoring. The most useful tools include 24-hour urine collections, urine volume, urinary cystine level or cystine capacity when available, urine pH, sodium excretion, urea nitrogen as a protein intake marker, kidney function, urinalysis for protein, imaging surveillance, and stone analysis.
Patients using tiopronin or D-penicillamine need monitoring for proteinuria, blood count changes, liver abnormalities, and medication intolerance.
Home urine pH testing can be helpful, but it should be interpreted carefully and confirmed with clinical follow-up.
The Bottom Line on the Integrative Approach to Cystinuria
Cystinuria is a genetic kidney disease that requires lifelong prevention, not just episodic stone treatment. Standard care remains essential, especially high fluid intake, urine alkalinization, dietary modification, monitoring, and cystine-binding medications when needed.
An integrative approach to cystinuria strengthens this foundation by focusing on hydration habits, urine pH support, moderate protein intake, sodium reduction, plant-forward nutrition, and long-term kidney protection.
The newest evidence suggests that protein intake has a moderate effect on urinary cystine excretion, while salt intake may have a smaller effect than previously assumed. However, the most powerful tools remain dilution and solubility: produce enough urine and keep cystine dissolved.
For patients, the message is hopeful. Cystinuria is genetic, but stone risk is not determined by genes alone. Daily choices, guided by careful monitoring and medical care, can make a meaningful difference.
